Can I get it?
Yes, if a doctor decides it is right for you. Modafinil is authorised in the EU and can be prescribed after a medical review.
Modafinil · Munich
Modafinil in Munich.
Not in our consultation yet. We are continuously onboarding new specialists — leave your email and we'll notify you, or explore the three areas we already cover.
NOTIFY ME WHEN AVAILABLE
Leave your email and we'll notify you when we add Modafinil.
NOT AVAILABLE TODAY
Hi-Doctor does not prescribe Modafinil yet.
Our licensed doctors currently focus on three areas with solid clinical evidence and a clear EU regulatory framework. We extend the catalogue as specialists join and regulation allows. Modafinil is outside the current scope.
Buying Modafinil online without a valid prescription carries counterfeiting and toxicity risks. Always consult a licensed healthcare professional.
IN PLAIN TERMS
What Modafinil is, and how to get treatment
Modafinil is a prescription medicine that helps people stay awake, and it is authorised in EU countries for one purpose only: the excessive daytime sleepiness of narcolepsy, a neurological sleep disorder. In 2011 the European Commission removed its other sleep indications after a safety review, so taking it for shift work, ordinary tiredness, focus or "cognitive enhancement" is off-label — outside anything an EU regulator has approved. It is a genuine medicine; it is simply prescribed by sleep and neurology specialists, not by us. Hi-Doctor treats hair loss, weight management and sexual health, and does not treat sleep disorders.
Modafinil is an authorised medicine in the EU, so a licensed doctor can prescribe it when it is clinically appropriate for you.
What can I take instead?
Our doctors review every option and recommend what fits your history and goals.
What do the studies show?
Every trial behind Modafinil is listed below with how many people took part and whether the results are peer-reviewed or a company announcement.
Jump to the studiesWHAT WE DO COVER
If your question fits one of these three areas, a licensed doctor reviews it in less than 2 hours on average for €35.
TREATMENTS
Three categories, one process.
Choose what fits. The journey is identical.
ONGOING PLANWeight loss
A medical consultation on your weight goal. Treatment if appropriate.
€25/month28-day treatment cycle
Explore weight lossONE-OFFSexual health
An absolutely discreet consultation for intimate concerns.
€35 one-offFull refund if not approved
Explore sexual healthONGOING PLANHair growth
Medical assessment and tailored treatment for hair loss.
€15/monthBilled €45 every 90 days
Explore hair growthLicensed EU doctors
Doctor review in less than 2 hours on average
50,000+ patients served
Secure patient account
VERIFIED EVIDENCE
Modafinil: evidence and regulatory guide.
WHAT IT IS
How it works
A wakefulness-promoting medicine that acts on the brain systems controlling sleep and alertness; its exact mechanism is still not fully understood.
- dopamine transporter (DAT)
DEVELOPMENT STAGE
EU-authorised medicine
Trial register1 registered trials
Every NCT identifier links to its ClinicalTrials.gov record. A readout is not the same as peer-reviewed publication.
| TRIAL / NCT | POPULATION | PARTICIPANTS | STATUS | READOUT / COMPLETION |
|---|---|---|---|---|
| US Modafinil in Narcolepsy Multicenter Study (9-week trial) | Adults with narcolepsy and excessive daytime sleepiness | 271 | Read out | — |
What the studies reported
Results are grouped by source and evidence grade so journal data and manufacturer announcements cannot be confused.
Peer-reviewed
US Modafinil in Narcolepsy Multicenter Study Group. Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy. Neurology 2000;54(5):1166-1175. doi:10.1212/WNL.54.5.1166| DOSE OR GROUP | MEAN WEIGHT CHANGE | WEEKS |
|---|---|---|
| 200 mg daily | Mean sleep latency on the Maintenance of Wakefulness Test increased by 40% versus placebo | 9 |
| 400 mg daily | Mean sleep latency on the Maintenance of Wakefulness Test increased by 54% versus placebo | 9 |
Everyone in this trial had diagnosed narcolepsy; the result says nothing about ordinary tiredness, shift work, or use for concentration in healthy people.
NAMED SAFETY SIGNALS
What has been reported with Modafinil.
Indication restricted by EU regulators
After an Article 31 safety review, the CHMP opinion of 18 November 2010 and the European Commission decision of 27 January 2011 restricted modafinil in the EU to narcolepsy only, withdrawing the obstructive sleep apnoea, shift-work sleep disorder and idiopathic hypersomnia indications.
Serious skin reactions
The EU review confirmed a link to rare but life-threatening skin reactions including Stevens-Johnson syndrome and toxic epidermal necrolysis, with higher risk in children; modafinil is not recommended in children.
Psychiatric reactions
The EU review found a link with psychiatric adverse reactions including suicidal thoughts, depression and psychotic episodes.
Cardiovascular effects
Associated with raised blood pressure and irregular heartbeat; the EU review advised against use in people with uncontrolled hypertension or arrhythmia.
HOW IT WORKS · 5 STEPS
Five steps. No waiting room.
From the online consultation to ongoing follow-up — without leaving home.
- 5 minutes
Start your online visit
Answer a 5-minute health questionnaire from home.
- Less than 2 hours
A doctor reviews your case
A licensed doctor reviews your answers and replies personally.
- Refund guarantee
Review and payment
If not approved, we refund your €35 one-off in full.
- EU pharmacies
Collect treatment from the pharmacy
Collect it at any EU pharmacy with your e-prescription.
- 4-week check-in
Ongoing support
Private chat, 4-week check-in, simple prescription renewal.
NOTIFY ME
Leave your email and we'll notify you when Modafinil becomes available.
We only use your email for this notification. You can opt out at any time.
FREQUENTLY ASKED QUESTIONS